BLOXIVERZ

Neostigmine methylsulfate · Exela Pharma Sciences, LLC

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for BLOXIVERZ, covering 2013-05-31 to 2023-10-27. Get the full timeline:

Most recent: FDA Approved: BLOXIVERZ — Supplemental Application (Exela Pharma Sciences, LLC)